ICD-10-CM Casefinding List
(FY 2014: October 1, 2013-September 30, 2014)

Note: ICD-10-CM was scheduled to go into effect on October 1, 2014. In April 2014, the date was changed to October 1, 2015. Continue to use ICD-9-CM for casefinding for 2014.

These tables are also available in a printable version (PDF).

COMPREHENSIVE ICD-10-CM Casefinding Code List for Reportable Tumors
(Effective 10/1/2013-9/30/2014)
Please refer to your standard setter(s) for specific reporting requirements before using the Casefinding list
ICD-10-CM CODE^ EXPLANATION OF ICD-10-CM CODE
C00._ - C43._, C45._ – C96._ Malignant neoplasms (excluding category C44), stated or presumed to be primary (of specified site) and certain specified histologies 1
C44.00, C44.09 Unspecified/other malignant neoplasm of skin of lip
C44.10_, C44.19_ Unspecified/other malignant neoplasm of skin of eyelid
C44.20_, C44.29_ Unspecified/other malignant neoplasm skin of ear and external auricular canal
C44.30_, C44.39_ Unspecified/other malignant neoplasm of skin of other/unspecified parts of face
C44.40, C44.49 Unspecified/other malignant neoplasm of skin of scalp & neck
C44.50_, C44.59_ Unspecified/other malignant neoplasm of skin of trunk
C44.60_, C44.69_ Unspecified/other malignant neoplasm of skin of upper limb, incl. shoulder
C44.70_, C44.79_ Unspecified/other malignant neoplasm of skin of lower limb, including hip
C44.80, C44.89 Unspecified/other malignant neoplasm of skin of overlapping sites of skin
C44.90, C44.99 Unspecified/other malignant neoplasm of skin of unspecified sites of skin
D00._ – D09._ In-situ neoplasms (Note: Carcinoma in situ of the cervix (CIN III-8077/2) and Prostatic Intraepithelial Carcinoma (PIN III-8148/2) are not reportable).
D18.02 Hemangioma of intracranial structures and any site
D18.1 Lymphangioma, any site (Note: Includes Lymphangiomas of Brain, Other parts of nervous system and endocrine glands, which are reportable)
D32._ Benign neoplasm of meninges (cerebral, spinal and unspecified)
D33._ Benign neoplasm of brain and other parts of central nervous system
D35.2 - D35.4 Benign neoplasm of pituitary gland, craniopharyngeal duct and pineal gland
D42._, D43._ Neoplasm of uncertain or unknown behavior of meninges, brain, CNS
D44.3 – D44.5 Neoplasm of uncertain or unknown behavior of pituitary gland, craniopharyngeal duct and pineal gland
D45 Polycythemia vera (9950/3)
D46._ Myelodysplastic syndromes (9980, 9982, 9983, 9985, 9986, 9989, 9991, 9992)
D47.1 Chronic myeloproliferative disease (9963/3)
D47.3 Essential (hemorrhagic) thrombocythemia (9962/3)
D47.4 Osteomyelofibrosis (9961/3)
D47.7 Other specified neoplasms of uncertain/unknown behavior of lymphoid, hematopoietic (9965/3, 9966/3, 9967/3, 9971/3, 9975/3)
D47.Z_ Neoplasm of uncertain behavior of lymphoid, hematopoietic and related tissue, unspecified (9960/3, 9970/1, 9931/3)
D47.9 Neoplasm of uncertain behavior of lymphoid, hematopoietic and related tissue, unspecified (9970/1, 9931/3)
D49.6, D49.7 Neoplasm of unspecified behavior of brain, endocrine glands and other CNS

1 Note: Pilocytic/juvenile astrocytoma M-9421 moved from behavior /3 (malignant) to /1 (borderline malignancy) in ICD-O-3. However, SEER registries will CONTINUE to report these cases and code behavior as /3 (malignant).

Return to top

NOTE: Cases with these codes should be screened as registry time allows. Experience in the SEER registries has shown that using the supplemental list increases casefinding for benign brain and CNS, hematopoietic neoplasms, and other reportable diseases

SUPPLEMENTAL LIST ICD-10-CM
(EFFECTIVE DATES: 10/1/2013-9/30/2014)
ICD-10-CM CODE^ EXPLANATION OF ICD-10-CM CODE
B20 Human immunodeficiency virus [HIV] disease with other diseases
Note: Excludes HIV with malignancy (B21), see reportable list
B97.33, B97.34,
B97.35
Human T-cell lymphotrophic virus,( type I [HTLV-1], type II [HTLV-II], type 2 [HIV 2]) as the cause of diseases classified elsewhere
B97.7 Papillomarvirus as the cause of diseases classified elsewhere
C44.01, C44.02 Basal/squamous cell carcinoma of skin of lip
C44.11_, C44.12_ Basal/squamous cell carcinoma of skin of eyelid
C44.21_, C44.22_ Basal/squamous cell carcinoma of skin of ear and external auricular canal
C44.31_, C44.32_ Basal/squamous cell carcinoma of skin of other and unspecified parts of face
C44.41, C44.42 Basal/squamous cell carcinoma of skin of scalp and neck
C44.51_, C44.52_ Basal/squamous cell carcinoma of skin of trunk
C44.61_, C44.62_ Basal/squamous cell carcinoma of skin of upper limb, including shoulder
C44.71_, C44.72_ Basal/squamous cell carcinoma of skin of lower limb, including hip
C44.81, C44.82 Basal/squamous cell carcinoma of skin of overlapping sites of skin
C44.91, C44.92 Basal/squamous cell carcinoma of skin of unspecified sites of skin
D10._ – D31._,
D34, D35.0,
D35.1, D35.5_
D35.9, D36._
Benign neoplasms (see “must collect” list for reportable benign neoplasms)
Note: Screen for incorrectly coded malignancies or reportable by agreement tumors
Note: Borderline cystadenomas M-8442, 8451, 8462, 8472, 8473, of the ovaries moved from behavior /3 (malignant) to /1 (borderline malignancy) in ICD-O-3. SEER registries are not required to collect these cases for diagnoses made 1/1/2001 and after. However, cases diagnosed prior to 1/1/2001 should still be abstracted and reported to SEER.
D3A._ Benign carcinoid tumors
D37._ – D41._ Neoplasms of uncertain or unknown behavior (see “must collect” list for reportable neoplasms of uncertain or unknown behavior)
Note: Screen for incorrectly coded malignancies or reportable by agreement tumors
D44.0 – D44.2,
D44.6-D44.9
Neoplasm of uncertain or unknown behavior of other endocrine glands (see “must collect” list for D44.3-D44.5)
Note: Screen for incorrectly coded malignancies or reportable by agreement tumors
D47.0 Histiocytic and mast cell tumors of uncertain behavior
D47.2 Monoclonal gammopathy
Note: Screen for incorrectly coded Waldenstrom’s macroglobulinemia
D48._ Neoplasm of uncertain behavior of other and unspecified sites
D49.0 – D49.9 Neoplasm of unspecified behavior (except for D49.6 and D49.7)
D61.18_ Pancytopenia
D63.0 Anemia in neoplastic disease
D64.81 Anemia due to antineoplastic chemotherapy
D69.49, D69.59,
D69.6
Other thrombocytopenia
Note: Screen for incorrectly coded thrombocythemia
D70.1 Agranulocytosis secondary to cancer chemotherapy
D72.1 Eosinophilia (Note: Code for eosinophilia (9964/3). Not every case of eosinophilia is a malignancy. Reportable Diagnosis is “Hypereosonophilic syndrome.”)
D76._ Other specified diseases with participation of lymphoreticular and reticulohistiocytic tissue
D89.0, D89.1 Other disorders involving the immune mechanism, not elsewhere classified
Note: Review for miscodes
E34.0 Carcinoid syndrome
E83.52 Hypercalcemia
E88.09 Other disorders of plasma-protein metabolism, not elsewhere classified
E88.3 Tumor lysis syndrome (following antineoplastic chemotherapy)
G89.3 Neoplasm related pain (acute)(chronic)
K22.711 Barrett’s esophagus with high grade dysplasia
K62.82 Dysplasia of anus (AIN I and AIN II)
K92.81 Gastrointestinal mucositis (ulcerated) (due to antineoplastic therapy)
N42.3 Dysplasia of prostate (PIN I and PIN II)
N87._ Dysplasia of cervix uteri (CIN I and CIN II)
N89.0, N89.1,
N89.3
Vaginal dysplasia (VIN I and VIN II)
N90.0, N90.1,
N90.3
Vulvar dysplasia (VAIN I and VAIN II)
O01._ Hydatidiform mole Note: Benign tumor that can become malignant. If malignant, report as Choriocarcinoma (9100/3, ) malignancy code in the C00- C97 range
Q85.0_ Neurofibromatosis (nonmalignant) (9540/1)
Note: Neurofibromatosis is not cancer. These tumors can be precursors to acoustic neuromas, which are reportable
R18.0 Malignant ascites
R53.0 Neoplastic (malignant) related fatigue
R59._ Enlarged lymph nodes
R85.6 Abnormal findings on cytological and histological examination of digestive organs
R87.61_, R87.62_ Abnormal findings on cytological/histological examination of female genital organs
R92._ Abnormal findings on diagnostic imaging of breast
R97._ Abnormal tumor markers
T38.8_, T38.9_ Poisoning by hormones and their synthetic substitutes
T45.1_ Poisoning by, adverse effect of and under dosing of antineoplastic and immunosuppressive drugs
T45.8_, T45.9_ Poisoning by primary systemic and hematological agent, unspecified
T66 Unspecified effects of radiation
T80.2_ Infections following infusion, transfusion and therapeutic injection
Y63.2 Overdose of radiation given during therapy
Y84.2 Radiological procedure and radiotherapy as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
Z03.89 Encounter for observation for other suspected diseases and conditions ruled out
Z08 Encounter for follow-up examination after completed treatment for malignant neoplasm
Z12._ Encounter for screening for malignant neoplasms
Z17.0, Z17.1 Estrogen receptor positive and negative status
Z40.0_ Encounter for prophylactic surgery for risk factors related to malignant neoplasms
Z42.1 Encounter for breast reconstruction following mastectomy
Z48.290 Encounter for aftercare following bone marrow transplant
Z51.0 Encounter for antineoplastic radiation therapy
Z51.1_ Encounter for antineoplastic chemotherapy and immunotherapy
Z51.5, Z51.89 Encounter for palliative care and other specified aftercare
Z85._ Personal history of malignant neoplasm
Z86.0_, Z86.01_,
Z86.03
Personal history of in situ and benign neoplasms and neoplasms of uncertain behavior
Z92.21, Z29.23,
Z92.25. Z92.3
Personal history of antineoplastic chemotherapy, estrogen therapy, immunosuppression therapy or irradiation (radiation)
Z94.81, Z94.84 Bone marrow and stem cell transplant status

^International Classification of Diseases, ICD-10-CM Tabular List of Diseases and Injuries, FY 2014

Return to top